HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changes of color vision in ocular hypertension.

Abstract
Fifty-six ocular hypertension (OHT) patients were examined for 2-3 days in the Eye Clinic of Kuopio University Hospital. No glaucomatous changes were found. Twenty-seven of them were found to have several risk factors for developing glaucoma and medication was started. Twenty-nine of the patients did not show risk factors and had no medication. Color vision was examined with the Farnsworth-Munsell 100 (FM 100) hue test and Besançon anomalometer, later Color Vision Meter 712 at the beginning of the study and 3 years later. None of the 56 patients showed any glaucomatous changes after 3 years of the study. In the treatment group, the FM 100 test showed significantly (paired t-test, p = 0.004) improved error scores after 3 years. In the non-treatment group, 19 patients did not develop risk factors; they had no significant changes in the color vision results. In 10 patients of the non-treatment group, risk factors had developed with elevated intraocular pressure and medication was started for them after 3 years. Their color vision results in the blue anomalous quotient (AQ) of the anomalometer had significantly shifted to the blue part of the equation (paired t-test, p = 0.04). The other color vision results had not changed significantly. The significantly improved FM 100 scores in the treatment group could mean, that the treatment has a beneficial effect for the OHT eyes at risk for developing glaucoma.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsM Mäntyjärvi, K Tuppurainen
JournalInternational ophthalmology (Int Ophthalmol) 1994-1995 Vol. 18 Issue 6 Pg. 345-9 ISSN: 0165-5701 [Print] Netherlands
PMID7642334 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Aged
  • Color Perception (physiology)
  • Color Perception Tests
  • Female
  • Follow-Up Studies
  • Humans
  • Intraocular Pressure
  • Male
  • Middle Aged
  • Ocular Hypertension (drug therapy, physiopathology)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: